Ads
related to: antibody
Search results
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days agoIn preclinical models of cornea endothelial dystrophies, a Surrozen antibody-based Wnt mimetic reduced corneal edema and stimulated endothelial cell proliferation in the corneaSurrozen ...
Pipeline Moves: Phase III completion for Corcept’s relaorilant
Clinical Trials Arena via Yahoo Finance· 2 days agoAlso, Lyvgen’s monoclonal antibody (mAb) dalnicastobart has seen its transition prospects increase...
iTeos Therapeutics (NASDAQ:ITOS) Sees Strong Trading Volume Following Analyst Upgrade
ETF DAILY NEWS· 6 hours agoiTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) saw an uptick in trading volume on Monday after HC Wainwright raised their price target on the stock from $44.00 to $46.00. HC Wainwright ...
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
Reuters via Yahoo News· 8 hours agoThe companies are seeking the Food and Drug Administration's (FDA) approval of a weekly dose of...
BioMarin cutting about 170 jobs after shuffling drug portfolio - San Francisco Business Times
The Business Journals· 7 hours agoMost of the employees hit by the cuts were told Tuesday, the company (NASDAQ: BMRN) said. BioMarin...
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
Digital Journal· 11 hours agoTop-line data from first-in-human Phase 1a clinical trial of PMN310 as a treatment for Alzheimer’s disease on track for mid-2024CAMBRIDGE, Massachusetts and TORONTO, Ontario, May 14, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 21 hours agoSanofi plans to invest €1bn in Vitry-sur-Seine to construct a new unit in a bid to double the...
Novo Nordisk's Hemlibra rival hits goals in phase 3, teeing up blockbuster showdown with Roche
FierceBiotech· 18 hours agoNovo Nordisk is coming for Roche’s Hemlibra. Novo Nordisk is taking the same approach to preventing...
Merck halts phase 3 TIGIT trial after immune-mediated adverse events prompt discontinuations
FierceBiotech· 2 days agoMerck & Co. has bailed early on a phase 3 test of the anti-TIGIT antibody vibostolimab after a high...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 12 hours agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...